All In MedTech

Device Trial Radar · NCT01792778

RIGHT IV Pilot Study

Post-Market Study Comparing the Clinical Performance Two Blood Control Safety Peripheral Intravenous Catheters: A Pilot Study

Last checked: Nov 20, 2026Latest source record: May 26, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Feb 2013

Primary completion

Feb 2013

Study completion Feb 2013

Sponsor

Lead sponsor
Smiths Medical, ASD, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 15, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Single (participant)
Primary purpose
Supportive care
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this pilot study is to collect the necessary information for determining the appropriate sample size of a statistically powered trial comparing the performance of two different blood control peripheral intravenous catheters.

Conditions

  • Peripheral Intravenous Catheters

Interventions

  • ViaValve Safety IV CatheterDevice

    Insertion of the peripheral intravenous catheters into both upper extremities of subjects

  • Insyte Autoguard BC [Blood Control] Shielded IV CatheterDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical performance and acceptabilityTime frame: IV catheters will be inserted, secured to subjects, and then immediately removed. Data regarding the insertion process will then be immediately collected.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Minnesota Interprofessional Education and Resource Center

    Minneapolis, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.